Amrize (AMRZ) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
27 Feb, 2026Executive summary
The 2026 Annual General Meeting will be held on April 21, 2026, with shareholders voting on key proposals including financial statements, executive compensation, board elections, and distributions.
Fiscal year 2025 marked the company's transition to an independent public entity, achieving 1% revenue growth to $11.8 billion and generating $1.5 billion in free cash flow.
Strategic investments included expansions at major cement plants and three bolt-on acquisitions, with a focus on operational efficiency and market expansion.
The company established new compensation and governance structures post-spin-off, aligning with U.S. and Swiss best practices.
Voting matters and shareholder proposals
Shareholders will vote on approval of annual and statutory financial statements, executive compensation (say-on-pay), frequency of say-on-pay votes, Swiss statutory remuneration, non-financial matters, loss offsetting, special and regular distributions, board and committee elections, auditor appointments, and discharge of liability.
Board recommends annual say-on-pay votes and proposes maximum aggregate compensation for the board ($3.6M) and executive management ($59M) for upcoming periods.
Proposals include special and regular distributions of $0.44 per share each, in up to four installments.
Board of directors and corporate governance
The board consists of nine members, with a majority qualifying as independent under NYSE and Swiss standards.
All current directors are nominated for re-election for one-year terms; Jan Jenisch is nominated for re-election as Chairman.
Board committees (Audit, Compensation, Nomination & Governance) are composed entirely of independent directors.
Board diversity: 33% female directors; skills include leadership, finance, industry, and governance expertise.
Latest events from Amrize
- 2026 AGM proxy covers key votes, governance, compensation, and ESG priorities.AMRZ
Proxy Filing12 Mar 2026 - AGM to address board elections, executive pay, distributions, and non-financial reporting.AMRZ
Proxy Filing12 Mar 2026 - 2026 guidance targets 4–6% revenue and 8–11% EBITDA growth, with strong shareholder returns.AMRZ
Q4 202518 Feb 2026 - Stable Q2 2025 results and synergy program support strong outlook and long-term growth.AMRZ
Q2 202523 Nov 2025 - Q3 revenue up 6.6% to $3,675M, net income $543M, 2025 guidance raised to $12.0B.AMRZ
Q3 202529 Oct 2025